Characteristics of male injectors of the IPEDs sampled
| Characteristic | n | ||
|---|---|---|---|
| Demographic | |||
| Age, years | Under25 | 27% | 106 |
| 25-34 | 34% | 134 | |
| 35 and over | 27% | 107 | |
| Median (IQR) | 28 (13) | ||
| Not reported | 12% | 48 | |
| Had ever been in prison | 16% | 63 | |
| Health service use | |||
| Had ever used a Needle and Syringe Programme | 75% | 298 | |
| Had seen a general practitioner in the last year about their health | 45% | 178 | |
| Had you got advice at an Accident & Emergency / Walk-in in the last year | 16% | 64 | |
| Had taken/used prescribed medication in last year | 28% | 111 | |
| Had sought advice from a sexual health / sexually transmitted infections clinic in the last year | 17% | 68 | |
| Had been vaccinated against hepatitis B | 23% | 90 | |
| Had had a blood test for hepatitis C | 22% | 85 | |
| Had had a blood test for HIV | 31% | 122 | |
| Symptom of injury or infection at injection site | |||
| Had ever had redness at an injection site | 43% | 168 | |
| Had ever had an injection site abscess/sore/open wound | 6.80% | 27 | |
| Image and performance enhancing drug use, last year | |||
| Years since first used an image and performance enhancing drug | 0-4 | 36% | 141 |
| 5+ | 32% | 128 | |
| Median (IQR) | 4 (8) | ||
| Not reported | 32% | 126 | |
| Oral anabolic steroids | 57% | 226 | |
| Oral anti-oestrogens | 23% | 92 | |
| Oral clenbuterol | 15% | 60 | |
| Oral ephedrine | 20% | 78 | |
| Oral thyroid hormones | 9% | 37 | |
| Oral phosphodiesterase type 5 inhibitor (PDE5i; “Viagra/Calias”) | 6.6% | 26 | |
| Oral other image and performance enhancing drug (inc. Diuretics, 2,4–dinitrophenol and Pro/designer) | 12% | 46 | |
| Injected anabolic steroids | 86% | 340 | |
| Injected growth hormone | 32% | 128 | |
| Injected human chorionic gonadotropin (hCG) | 16% | 62 | |
| Injected insulin injected | 5.6% | 22 | |
| Injected melanotan | 8.6% | 34 | |
| Injected other image and performance enhancing drug (inc. ethryopoetin, insulin–like growth factor 1 and nalbuphine hydrochloride) | 5.1% | 20 | |
| Use of other illicit drugs | |||
| Ever injected illicit drug other than an image and performance enhancing drug. | 4.8% | 19 | |
| Snorted cocaine in the last year | 46% | 181 | |
| Snorted, drunk or swallowed amphetamine in last year | 12% | 47 | |
| Injecting practice | |||
| Who usually injected you, last year? | Someone else | 17% | 68 |
| Myself | 74% | 294 | |
| Not reported | 8.4% | 33 | |
| Intramuscular injection in the last year | 88% | 346 | |
| Subcutaneous injection in the last year | 39% | 154 | |
| Ever shared needle, syringe or vial | 8.9% | 35 | |
| Sexual behaviour | |||
| Number of sexual partners last year | One | 38% | 152 |
| Two or more | 47% | 187 | |
| Not reported/no sex | 14% | 56 | |
| Gender of sexual partners last year | Male partner(s) | 3.3% | 13 |
| No male partners | 82% | 323 | |
| Not reported/no sex | 15% | 59 | |
| Always condom (anal/vaginal sex) or no sex last year | 20% | 78 | |